dexketoprofen trometamol is one of 150 small molecule programs targeting Dysmenorrhea. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
357 competitors in Migraine
dexketoprofen trometamol
Aimovig
Emgality
Vyepti
Bayer Aspirin
Savella
Cymbalta
Pristiq
Lidocain
Bupivacaine Only
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources